Evaluation of Bivalirudin in Percutaneous Coronary Intervention
No Thumbnail Available
Meeting name
Sponsors
Date
Journal Title
Format
Article
Abstract
The aim of this study was to analyze the appropriateness of bivalirudin utilization indicated for percutaneous coronary interventions (PCI). A total of 218 patients who were admitted to University of Missouri Health Care that underwent a PCI were included in this retrospective study. Analysis was conducted for appropriate utilization of bivalirudin in patients with a history of heparin induced thrombocytopenia (HIT) over unfractionalized heparin. Bivalirudin use was found to be inappropriate in 170 of the 218 patients evaluated (78[percent]). By using, none experienced minimal bleeding, 15 experienced minor bleeding, three experienced major bleeding per the thrombolysis in myocardial infarction (TIMI) bleeding criteria, and none died as a result of bleeding complications.
Table of Contents
DOI
PubMed ID
Degree
Thesis Department
Rights
OpenAccess.
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License.